Hints and tips:
...Jacob Van Naarden, president of the company’s oncology division Loxo@Lilly, said the acquisition of Point would be the “beginning of our investment in developing multiple meaningful radioligand medicines...
...Originally developed by physicists from CERN, the European organisation for nuclear research, Novartis’s radioligand therapy delivers beta radiation to tumours through an infusion, which is more targeted...
...Varian is a world leader in the field of cancer care, in particular radiation oncology, and uses artificial intelligence, machine learning and data analysis to improve cancer treatment....
...Here’s Goldman: Varian is the market leader in the global radiation oncology market, with c.60% market share, with Elekta the other sizeable player, at c.40% market share....
...(Guardian, 19m) Climate change and cancer From air pollution and lung cancer to ultraviolet radiation and skin cancers, a discussion of how climate change is affecting cancer control....
...build, has sparked safety fears and concerns over the environmental impact of any mishap, amid concern over a botched nuclear missile test this month at a military site close to Murmansk that released a radiation...
...When top cancer doctors gathered for the annual meeting of the American Society of Clinical Oncology last weekend, faster detection of the illness was on medics’ minds....
...State-backed conglomerate China Resources and Australia’s Macquarie Group bought a controlling stake in the country’s largest provider of radiation oncology treatment, GenesisCare, for about A$1.7bn in 2016...
...But Goldman Sachs advised caution, arguing that a lack of licences “has not historically been a limiting factor to radiation oncology market growth in China”....
...The Food and Drug Administration has approved Imfinzi for treating stage three lung cancer patients who have already received chemotherapy and radiation therapy treatment, and whose disease has not spread...
...Scott Antonia, the investigator in the Pacific trial who chairs the Thoracic Oncology Department at the H....
...harmful radiation....
...Dave Fredrickson, who heads the oncology business unit at AstraZeneca, decribed the approval as a “truly meaningful milestone for patients who, until now, had no FDA-approved treatment options following...
...Sean Bohen, chief medical officer at AstraZeneca, said Imfinzi was the first “immuno-oncology” drug to show a benefit for people with lung cancer for whom chemotherapy had stopped working but who had not...
...“We are where oncology was 10 or 12 years ago, when most tumours were thought to be intractable and could only be treated with chemotherapy or radiation,” says Mr Holcombe....
...In September 2010, Mr Fogel emailed Mr Huber about the government’s future payments plans for radiation oncology treatments....
...Radiotherapy is “not always used to its full potential”, adds Ricky Sharma, UCL professor of radiation oncology....
...The initiative is part of a wider move by oncology researchers to discover ways to stop the normal evolution of tumours into more lethal forms that resist treatment....
...His observations of Hawking radiation, in a paper published in August, shook the academic world. To many, Stephen Hawking’s theory that black holes emit particles over time was finally proved....
...In my essays, I focused on the upcoming challenges for radiation oncology in the near future and how an MBA will help me to overcome them....
...This finding is encouraging because more mutated cancers are generally more aggressive and harder to treat with conventional drugs, radiation or surgery....
...This NanoXray technology has begun clinical testing in patients with advanced soft tissue sarcoma, with promising results reported at the American Society of Clinical Oncology meeting earlier this month....
...“We can also increase the dose rate [of radiation], cutting the number of treatments for patients,” says Dee Mathieson, senior vice-president of Elekta’s oncology division....
...His hospital has limited resources: radiation therapy was not an option since there was only one machine in Yangon and the waiting time could stretch to months....
...Clifford Chao, chief of radiation oncology at New York-Presbyterian Hospital....
International Edition